ArticleGynecologic oncology2020

A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy.

Lynn K H Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.